carbostyril has been researched along with B16 Melanoma in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Janošková, M; Jantová, S; Milata, V; Pánik, M; Paulovičová, E; Paulovičová, L | 1 |
| Avendaño-Guzmán, E; Bernhardt, G; Brück, W; Dreyer, C; Harden, M; Nessler, S; Ott, M; Schön, M; Schön, MP; Stadelmann, C; Strauss, J; Ullrich, E; Wegner, C | 1 |
| Abrams, SI; Adelaiye, R; Celander, M; Ciamporcero, E; Ciesielski, M; Ellis, L; Eriksson, H; Fenstermaker, R; Leanderson, T; Miles, KM; Olsson, A; Orillion, A; Pili, R; Ramakrishnan, S; Shen, L; Sundstedt, A | 1 |
| Arulselvan, P; Chang, WT; Chen, HM; Chen, SS; Chou, LC; Huang, LT; Kuo, SC; Wei, WC; Wen, CC; Wu, JB; Yang, NS | 1 |
| Kobayashi, K; Kosano, H; Nishigori, H; Setogawa, T | 1 |
| Ashizawa, T; Hosomi, J; Morimoto, M; Nakano, H; Yamashita, Y | 1 |
6 other study(ies) available for carbostyril and B16 Melanoma
| Article | Year |
|---|---|
Immunobiological efficacy and immunotoxicity of novel synthetically prepared fluoroquinolone ethyl 6-fluoro-8-nitro-4-oxo-1,4-dihydroquinoline-3-carboxylate.
Topics: Animals; Antineoplastic Agents; Apoptosis; Caspase 9; Cell Growth Processes; Cell Survival; Cytokines; Epidermis; Female; Fibroblasts; Fluoroquinolones; HeLa Cells; HL-60 Cells; Humans; Immunologic Factors; Melanoma; Melanoma, Experimental; Mice; NIH 3T3 Cells; Quinolines; Quinolones; RAW 264.7 Cells; Uterine Cervical Neoplasms | 2018 |
Laquinimod, a prototypic quinoline-3-carboxamide and aryl hydrocarbon receptor agonist, utilizes a CD155-mediated natural killer/dendritic cell interaction to suppress CNS autoimmunity.
Topics: Animals; Antigens, Differentiation, T-Lymphocyte; Autoimmunity; Dendritic Cells; Encephalomyelitis, Autoimmune, Experimental; Humans; Immunologic Surveillance; Killer Cells, Natural; Lymphocyte Activation; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Transgenic; Quinolines; Quinolones; Receptors, Aryl Hydrocarbon; Receptors, Virus | 2019 |
Tasquinimod modulates suppressive myeloid cells and enhances cancer immunotherapies in murine models.
Topics: Animals; Antineoplastic Agents; Cancer Vaccines; Castration; CD8-Positive T-Lymphocytes; Combined Modality Therapy; Drug Evaluation, Preclinical; Immune Tolerance; Immunotherapy; Male; Melanoma, Experimental; Mice, Inbred C57BL; Myeloid Cells; Neoplasm Transplantation; Prostatic Neoplasms; Quinolines; Quinolones; T-Lymphocyte Subsets | 2015 |
Specific microtubule-depolymerizing agents augment efficacy of dendritic cell-based cancer vaccines.
Topics: Adjuvants, Immunologic; Animals; Cancer Vaccines; Cell Death; Cell Line, Tumor; Colchicine; Dendritic Cells; Lymphocyte Activation; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Quinolones | 2011 |
Pyrroloquinoline quinone (PQQ) inhibits the expression of tyrosinase mRNA by alpha-melanocyte stimulating hormone in murine B16 melanoma cells.
Topics: alpha-MSH; Animals; Base Sequence; Coenzymes; Cyclic AMP; Drug Interactions; Kinetics; Melanins; Melanoma, Experimental; Mice; Molecular Sequence Data; Monophenol Monooxygenase; Polymerase Chain Reaction; PQQ Cofactor; Quinolones; RNA, Messenger; Transcription, Genetic; Tumor Cells, Cultured | 1995 |
Antitumor quinolones with mammalian topoisomerase II mediated DNA cleavage activity.
Topics: Animals; Antineoplastic Agents; DNA Topoisomerases, Type II; DNA, Neoplasm; DNA, Superhelical; Enzyme Induction; Leukemia P388; Male; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Quinolones; Structure-Activity Relationship | 1992 |